
|Articles|March 17, 2010
Supplements and Featured Publications
- Implications of Early Treatment for Parkinson’s Disease [CME/CPE]
- Volume 16
- Issue 4
Posttest: Implications of Early Treatment for Parkinson's Disease
Advertisement
Instructions
After reading “Implications of Early Treatment for Parkinson’s Disease,” complete the program evaluation and select the 1 best answer to each of the following questions.
A statement of continuing education hours will be provided to those physicians and pharmacists who successfully complete and return the answer form and program evaluation and receive a passing grade of 70% or higher.
Articles in this issue
over 15 years ago
Participating Facultyover 15 years ago
Early Pharmacologic Treatment in Parkinson's DiseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Medicaid Work Requirements Set to Leave Millions Without Insurance
3
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
4
Baricitinib Leads to Significant Hair Regrowth in Adolescents With Severe Alopecia Areata
5















































